• Romero-Castro NS, Castro-Alarcón N, Reyes-Fernández S, Flores-Alfaro E, Serna-Radilla VO, Parra-Rojas I. Periodontal Disease Distribution, Risk Factors, and Importance of Primary Healthcare in theClinical Parameters Improvement. Int. J. Odontostomat. 2020;14(2):183-190. https://doi.org/10.4067/S0718-381X2020000200183
• Bautista-Herrera LA, De la Cruz-Mosso U, Román-Fernández IV, Parra-Rojas I, Soñanez-Organis JG, Hernández-Bello J, Morales-Zambrano RA, Villanueva-Quintero GD, Muñoz-Valle JF. A potential inflammatory role of IL-31 in psoriatic arthritis: A correlation with Th17 cytokine profile. Int J Immunopathol Pharmacol. 2020;34:2058738420907186. https://doi.org/10.1177/2058738420907186
• Anaya-Macias BU, De la Cruz-Mosso U, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla G, González-López L, Gámez-Nava JI, Pérez-Guerrero EE, Barrientos-Avalos SL, Muñoz-Valle JF. The -675 4G/5G PAI-1 polymorphism confers genetic susceptibility to systemic lupus erythematosus, its clinical manifestations, and comorbidities in Mexican-Mestizo population. Autoimmunity. 2019:1-7. https://doi.org/10.1080/08916934.2019.1700957
• Santoscoy-Ascencio G, Baños-Hernández CJ, Navarro-Zarza JE, Hernández-Bello J, Bucala R, López-Quintero A, Valdés-Alvarado E, Parra-Rojas I, Illades-Aguiar B, Muñoz-Valle JF. Macrophage migration inhibitory factor promoter polymorphisms are associated with disease activity in rheumatoid arthritis patients from Southern Mexico. Mol Genet Genomic Med. 2019:e1037. https://doi.org/10.1002/mgg3.1037
• Meza-Meza MR, Vizmanos-Lamotte B, Muñoz-Valle JF, Parra-Rojas I, Garaulet M, Campos-López B, Montoya-Buelna M, Cerpa-Cruz S, Martínez-López E, Oregon-Romero E, De la Cruz-Mosso U. Relationship of Excess Weight with Clinical Activity and Dietary Intake Deficiencies in Systemic Lupus Erythematosus Patients. Nutrients. 2019;11(11). pii: E2683. https://doi.org/10.3390/nu11112683
• Barragán-Bonilla MI, Mendoza-Bello JM, Aguilera P, Parra-Rojas I, Illades-Aguiar B, Ramírez M, Espinoza-Rojo M. Combined Administration of Streptozotocin and Sucrose Accelerates the Appearance of Type 2 Diabetes Symptoms in Rats. J Diabetes Res. 2019;2019:3791061. https://doi.org/10.1155/2019/3791061
• Lomelí-Nieto JA, Muñoz-Valle JF, Baños-Hernández CJ, Navarro-Zarza JE, Ramírez-Dueñas MG, Sánchez-Hernández PE, Machado-Sulbaran AC, Parra-Rojas I, García-Chagollán M, Hernández-Bello J. TNFA -308G>A and -238G>A polymorphisms and risk to systemic sclerosis: impact on TNF-α serum levels, TNFA mRNA expression, and autoantibodies. Clin Exp Med. 2019;19(4):439-447. https://doi.org/10.1007/s10238-019-00569-4
• Navarro-Zarza JE, Muñoz-Valle JF, Baños-Hernández CJ, Parra-Rojas I, Reyes-Castillo Z, Rangel-Villalobos H, Hernández-Bello J. PRL -1149T allele (rs1341239) is associated with decreased risk of rheumatoid arthritis in population from southern Mexico: analysis of mRNA expression and PRL serum levels. Clin Rheumatol. 2019. https://doi.org/10.1007/s10067-019-04517-1
• Baños-Hernández CJ, Navarro-Zarza JE, Bucala R, Hernández-Bello J, Parra-Rojas I, Ramírez-Dueñas MG, García-Arellano S, Hernández-Palma LA, Machado-Sulbarán AC, Muñoz-Valle JF. Macrophage migration inhibitory factor polymorphisms are a potential susceptibility marker in systemic sclerosis from southern Mexican population: association with MIF mRNA expression and cytokine profile. Clin Rheumatol. 2019. https://doi.org/10.1007/s10067-019-04459-8
• Machado-Sulbaran AC, Ramírez-Dueñas MG, Navarro-Zarza JE, Muñoz-Valle JF, Mendoza-Carrera F, Baños-Hernández CJ, Parra-Rojas I, Montoya-Buelna M, Sánchez-Hernández PE. KIR/HLA Gene Profile Implication in Systemic Sclerosis Patients from Mexico. J Immunol Res. 2019;2019:6808061. https://doi.org/10.1155/2019/6808061
• García-Arellano S, Hernández-Palma LA, Bucala R, Hernández-Bello J, De la Cruz-Mosso U, García-Iglesias T, Cerpa-Cruz S, Padilla-Gutiérrez JR, Valle Y, Soñanez-Organis JG, Parra-Rojas I, Pereira-Suárez AL, Muñoz-Valle JF. Th1/Th17 Cytokine Profile is Induced by Macrophage Migration Inhibitory Factor in Peripheral Blood Mononuclear Cells from Rheumatoid Arthritis Patients. Curr Mol Med. 2018;18(10):679-688. https://doi.org/1566524019666190129123240
• Hernández-Palma LA, García-Arellano S, Bucala R, Llamas-Covarrubias MA, De la Cruz-Mosso U, Oregon-Romero E, Cerpa-Cruz S, Parra-Rojas I, Plascencia-Hernández A, Muñoz-Valle JF. Functional MIF promoter haplotypes modulate Th17-related cytokine expression in peripheral blood mononuclear cells from control subjects and rheumatoid arthritis patients. Cytokine. 2019;115:89-96. https://doi.org/10.1016/j.cyto.2018.11.014
• Ruiz-Noa Y, Hernández-Bello J, Llamas-Covarrubias MA, Palafox-Sánchez CA, Oregon-Romero E, Sánchez-Hernández PE, Ramírez-Dueñas MG, Parra-Rojas I, Muñoz-Valle JF. PTPN22 1858C>T polymorphism is associated with increased CD154 expression and higher CD4+ T cells percentage in rheumatoid arthritis patients. J Clin Lab Anal. 2019;33(3):e22710. https://doi.org/10.1002/jcla.22710
• Castro-Alarcón N, Rodríguez-García R, Ruíz-Rosas M, Muñoz-Valle JF, Guzmán-Guzmán IP, Parra-Rojas I, Vázquez-Villamar M. Association between TLR4 polymorphisms (896 A>G, 1196 C>T, - 2570 A>G, - 2081 G>A) and virulence factors in uropathogenic Escherichia coli. Clin Exp Med. 2019;19(1):105-113. https://doi.org/10.1007/s10238-018-0527-0
• Hernández-Bello J, Palafox-Sanchez CA, García-Arellano S, Reyes-Castillo Z, Pereira-Suárez AL, Parra-Rojas I, Navarro-Zarza JE, De la Cruz-Mosso U, Torres-Carrillo NM, Muñoz-Valle JF. Association of extrapituitary prolactin promoter polymorphism with disease susceptibility and anti-RNP antibodies in Mexican patients with systemic lupus erythematosus. Arch Med Sci. 2018;14(5):1025-1032. https://doi.org/10.5114/aoms.2016.62138
• Angel-Chávez LI, Ruelas-Cinco E, Hernández-Bello J, Castro E, Vázquez-Villamar M, Parra-Rojas I, Brennan-Bourdon LM, Muñoz-Barrios S, Guerrero-Velázquez C, Muñoz-Valle JF. Influence of serum leptin levels and Q223R leptin receptor polymorphism on clinical characteristic of patients with rheumatoid arthritis from Western Mexico. EJIFCC. 2018;29(1):26-35. https://europepmc.org/articles/pmc5949616
• Matia-García I, Salgado-Goytia L, Ramos-Arellano LE, Muñoz-Valle JF, Armenta-Solís A, Garibay-Cerdenares OL, Ramírez M, Parra-Rojas I. A possible association between the -2518 A>G MCP-1 polymorphism and insulin resistance in school children. Arch Endocrinol Metab. 2018;62(1):79-86. https://doi.org/10.20945/2359-3997000000012
• De la Cruz-Mosso U, García-Iglesias T, Bucala R, Estrada-García I, González-López L, Cerpa-Cruz S, et al. MIF promotes a differential Th1/Th2/Th17 inflammatory response in human primary cell cultures: Predominance of Th17 cytokine profile in PBMC from healthy subjects and increase of IL-6 and TNF-α in PBMC from active SLE patients. Cell Immunol. 2018;324:42-9. https://doi.org/10.1016/j.cellimm.2017.12.010
• Ramirez-Vargas MA, Flores-Alfaro E, Uriostegui-Acosta M, Alvarez-Fitz P, Parra-Rojas I, Moreno-Godinez ME. Effects of exposure to malathion on blood glucose concentration: a meta-analysis. Environ Sci Pollut Res Int. 2018;25(4):3233-42. https://doi.org/10.1007/s11356-017-0890-5
• Hernández-Bello J, Palafox-Sanchez CA, García-Arellano S, Reyes-Castillo Z, Pereira-Suárez AL, Parra-Rojas I, Navarro-Zarza JE, De la cruz-Mosso U, Torres-Carrillo NM, Munoz-Valle JF. Association of extrapituitary prolactin promoter polymorphism with disease susceptibility and anti-RNP antibodies in Mexican patients with systemic lupus erythematosus. Arch Med Sci 2018;14,5:1025–1032. https://doi.org/10.5114/aoms.2016.62138
• Ramírez-Pérez S, De la Cruz-Mosso U, Hernández-Bello J, Martínez-Bonilla GE, Ramírez-Dueñas MG, Pereira-Suárez AL, Parra Rojas I, Martínez-López E, Macías-Barragán J, Muñoz-Valle JF. High expression of interleukine-1 receptor antagonist in rheumatoid arthritis: Association with IL1RN*2/2 genotype. Autoimmunity. 2017;50(8):468-75. https://doi.org/10.1080/08916934.2017
• Machado-Sulbaran AC, Muñoz-Valle JF, Ramírez-Dueñas MG, Baños-Hernández CJ, Graciano-Machuca O, Velarde-De la Cruz EE, Parra-Rojas I, Sánchez-Hernández PE. Distribution of KIR genes and KIR2DS4 gene variants in two Mexican Mestizo populations. Hum Immunol. 2017;78(10):614-20. https://doi.org/10.1016/j.humimm.2017.07.010
• Mónica Ramírez, Olga Lilia Garibay-Cerdenares, Verónica I. Martínez-Santos, Isela Parra-Rojas. Obesidad y análisis proteómico: Su utilidad en la búsqueda de biomarcadores y blancos terapéuticos de enfermedades metabólicas. Invest Clin. 58(3):107-118, 2017.
• Baños-Hernández CJ, Navarro-Zarza JE, Parra-Rojas I, Vázquez-Villamar M, Ramón Padilla-Gutiérrez J, Valle Y, Reyes-Castillo Z, Magdalena Torres-Carrillo N, García-Arellano S, Brennan-Bourdon LM, Muñoz-Valle JF. PADI4 polymorphisms and the functional haplotype are associated with increased rheumatoid arthritis susceptibility: A replication study in a Southern Mexican population. Hum Immunol. 2017;78(9):553-8. https://doi.org/10.1016/j.humimm.2017.05.005
• Rodríguez-Reyes RR, Navarro-Zarza JE, Tello-Divicino TL, Parra-Rojas I, Zaragoza-García O, Guzmán-Guzmán IP. [Detection of cardiovascular risk in healthcare workers on the basis of WHO/JNC 7/ATP III criteria]. Rev Med Inst Mex Seguro Soc. 2017;55(3):300-8. http://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/article/view/284
• Muñoz-Valle JF, Padilla-Gutiérrez JR, Hernández-Bello J, Ruiz-Noa Y, Valle Y, Palafox-Sánchez CA, Parra-Rojas I, Gutiérrez-Ureña SR, Rangel-Villalobos H. PTPN22 -1123G>C polymorphism and anti-cyclic citrullinated protein antibodies in rheumatoid arthritis. Med Clin (Barc). 2017;149(3):95-100. https://doi.org/10.1016/j.medcli.2017.01.025
• Domínguez-Reyes T, Quiroz-Vargas I, Salgado-Bernabé AB, Salgado-Goytia L, Muñoz-Valle JF, Parra-Rojas I. Anthropometric measurements as predictive indicators of metabolic risk in a Mexican population. Nutr Hosp. 2017;34(1):96-101. https://doi.org/10.20960/nh.983
• Salgado-Bernabé AB, Ramos-Arellanol LE, Guzmán-Guzmán IP, Muñoz-Valle JF, Castro-Alarcón N, Vences-Velázquez A, Salga-do-Goytia L, Parra-Rojas I. Significant associations between C-reactive protein levels, body adiposity distribution and peripheral blood cells in school-age children. Invest Clin. 2016;57(2):120-30. http://www.redalyc.org/html/3729/372945989002/
• Matia-García I, Muñoz-Valle JF, Reyes-Castillo Z., García-Arellano J, Salgado-Bernabé AB, Alarcón -Romero LC, Vences-Velázquez A, Parra-Rojas I. Correlation between cytokine profile and metabolic abnormalities in young subjects. Int J Clin Exp Med 2016;9(8):16596-16604. /ISSN:1940-5901/IJCEM0026363
• Guzmán-Guzmán IP, Zaragoza-García O, Vences-Velázquez A, Castro-Alarcón N, Muñoz-Valle JF, Parra-Rojas I. [Circulating levels of MCP-1, VEGF-A, sICAM-1, sVCAM-1, sE-selectin and sVE-cadherin: Relationship with components of metabolic syndrome in young population]. Med Clin (Barc). 2016;147(10):427-34. https://doi.org/10.1016/j.medcli.2016.06.028
• de la Cruz-Mosso U, Elena Ramos-Arellano L, Francisco Muñoz-Valle J, Berenice Salgado-Bernabé A, Salgado-Goytia L, Castro-Alarcón N, Ramírez-Peralta A, Parra-Rojas I. PAI-1 haplogenotype confers genetic susceptibility for obesity and hypertriglyceridemia in Mexican children. Invest Clin. 2016;57(3):246-58. http://www.redalyc.org/html/3729/372946635003/
• Miranda-Estrada LI, Ruíz-Rosas M, Molina-López J, Parra-Rojas I, González-Villalobos E, Castro-Alarcón N. Relationship between virulence factors, resistance to antibiotics and phylogenetic groups of uropathogenic Escherichia coli in two locations in Mexico. Enferm Infecc Microbiol Clin. 2017;35(7):426-33. https://doi.org/10.1016/j.eimc.2016.02.021
• Radilla-Vázquez RB, Parra-Rojas I, Martínez-Hernández NE, Márquez-Sandoval YF, Illades-Aguiar B, Castro-Alarcón N. Gut Microbiota and Metabolic Endotoxemia in Young Obese Mexican Subjects. Obes Facts. 2016;9(1):1-11. https://doi.org/10.1159/000442479
• Marino-Ortega LA, Molina-Bello A, Polanco-García JC, Muñoz-Valle JF, Salgado-Bernabé AB, Guzmán-Guzmán IP, Parra-Rojas I. Correlation of leptin and soluble leptin receptor levels with anthropometric parameters in mother-newborn pairs. Int J Clin Exp Med. 2015;8(7):11260-7. https://europepmc.org/articles/pmc4565316
• Domínguez-Reyes T, Astudillo-López CC, Salgado-Goytia L, Muñoz-Valle JF, Salgado-Bernabé AB, Guzmán-Guzmán IP, Castro-Alarcón N, Moreno-Godínez ME, Parra-Rojas I. Interaction of dietary fat intake with APOA2, APOA5 and LEPR polymorphisms and its relationship with obesity and dyslipidemia in young subjects. Lipids Health Dis. 2015;14:106. https://doi.org/10.1186/s12944-015-0112-4
• Reyes-Castillo Z, Palafox-Sánchez CA, Parra-Rojas I, Martínez-Bonilla GE, del Toro-Arreola S, Ramírez-Dueñas MG, Ocampo-Bermudes G, Muñoz-Valle JF. Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features. Clin Exp Immunol. 2015;182(2):119-31. https://doi.org/10.1111/cei.12677
• Salazar Ruiz EN, Márquez Sandoval YF, Vizmanos Lamotte B, Altamirano Martínez MB, Salgado Bernabé AB, Salgado Goytia L, Muñoz Valle JF, Parra Rojas I. [Association between food behavior and hypercholesterolemia-LDL in university students]. Nutr Hosp. 2015;31(6):2696-702. https://doi.org/10.3305/nh.2015.31.6.8806
• Matia-García I, Salgado-Goytia L, Muñoz-Valle JF, García-Arellano S, Hernández-Bello J, Salgado-Bernabé AB, Parra Rojas I. Macrophage migration inhibitory factor promoter polymorphisms (-794 CATT 5-8 and -173 G>C): relationship with mRNA expression and soluble MIF levels in young obese subjects. Dis Markers. 2015;2015:461208. https://doi.org/10.1016/j.imlet.2014.10.029
• Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, Villanueva-Quintero GD, Padilla-Gutiérrez JR, Valle Y, Parra-Rojas I, Rangel-Villalobos H, Gutiérrez-Ureña SR, Muñoz-Valle JF. Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNFα in psoriatic arthritis. Int J Clin Exp Med. 2014;7(9):2605-14. https://europepmc.org/articles/pmc4211766
• Matia-García I, de la Cruz-Mosso U, Muñoz-Valle JF, Parra-Rojas I. [Macrophage migration inhibitory factor and its relationship with obesity and diabetes]. Invest Clin. 2014;55(3):266-77. https://europepmc.org/abstract/med/25272526
• Cruz-Mora J, Martínez-Hernández NE, Martín del Campo-López F, Viramontes-Hörner D, Vizmanos-Lamotte B, Muñoz-Valle JF, García-García G, Parra-Rojas I, Castro-Alarcón N. Effects of a symbiotic on gut microbiota in Mexican patients with end-stage renal disease. J Ren Nutr. 2014;24(5):330-5. https://doi.org/10.1053/j.jrn.2014.05.006
• Ramos-Arellano LE, Muñoz-Valle JF, De la Cruz-Mosso U, Salgado-Bernabé AB, Castro-Alarcón N, Parra-Rojas I. Circulating CD36 and oxLDL levels are associated with cardiovascular risk factors in young subjects. BMC Cardiovasc Disord. 2014;14:54. https://doi.org/10.1186/1471-2261-14-54
• Guzmán-Guzmán IP, Salgado-Bernabé AB, Muñoz Valle JF, Vences-Velázquez A, Parra-Rojas I. [Prevalence of metabolic syndrome in children with and without obesity]. Med Clin (Barc). 2015;144(5):198-203. https://doi.org/10.1016/j.medcli.2013.10.033
• De la Cruz-Mosso U, Bucala R, Palafox-Sánchez CA, Parra-Rojas I, Padilla-Gutiérrez JR, Pereira-Suárez AL, Rangel-Villalobos H, Vázquez-Villamar M, Angel-Chávez LI, Muñoz-Valle JF. Macrophage migration inhibitory factor: association of -794 CATT5-8 and -173 G>C polymorphisms with TNF-α in systemic lupus erythematosus. Hum Immunol. 2014;75(5):433-9. https://doi.org/10.1016/j.humimm.2014.02.014
• Parra-Rojas I, Del Moral-Hernández O, Salgado-Bernabé AB, Guzmán-Guzmán IP, Salgado-Goytia L, Muñoz-Valle JF. Adenovirus-36 seropositivity and its relation with obesity and metabolic profile in children. Int J Endocrinol. 2013;2013:463194. https://doi.org/10.1155/2013/463194
• Ramos-Arellano LE, Salgado-Bernabé AB, Guzmán-Guzmán IP, Salgado-Goytia L, Muñoz-Valle JF, Parra-Rojas I. CD36 haplotypes are associated with lipid profile in normal-weight subjects. Lipids Health Dis. 2013;12:167. https://doi.org/10.1186/1476-511X-12-167
• de la Cruz-Mosso U, Muñoz-Valle JF, Salgado-Bernabé AB, Castro-Alarcón N, Salgado-Goytia L, Sánchez-Corona J, Flores-Martínez SE, Parra-Rojas I. Body adiposity but not insulin resistance is associated with -675 4G/5G polymorphism in the PAI-1 gene in a sample of Mexican children. J Pediatr (Rio J). 2013;89(5):492-8. https://doi.org/10.1016/j.jped.2013.01.004
• Torres-Carrillo N, Ontiveros-Mercado H, Torres-Carrillo NM, Parra-Rojas I, Rangel-Villalobos H, Ramírez-Dueñas MG, Gutiérrez-Ureña SR, Valle Y, Muñoz-Valle JF. The -319C/+49G/CT60G haplotype of CTLA-4 gene confers susceptibility to rheumatoid arthritis in Mexican population. Cell Biochem Biophys. 2013;67(3):1217-28. https://doi.org/10.1007/s12013-013-9640-6
• Llamas-Covarrubias MA, Valle Y, Bucala R, Navarro-Hernández RE, Palafox-Sánchez CA, Padilla-Gutiérrez JR, Parra-Rojas I, Bernard-Medina AG, Reyes-Castillo Z, Muñoz-Valle JF. Macrophage migration inhibitory factor (MIF): genetic evidence for participation in early onset and early stage rheumatoid arthritis. Cytokine. 2013;61(3):759-65. https://doi.org/10.1016/j.cyto.2012.12.032
• Muñoz-Valle JF, Oregón-Romero E, Rangel-Villalobos H, Martínez-Bonilla GE, Castañeda-Saucedo E, Salgado-Goytia L, Leyva-Vázquez MA, Illades-Aguiar B, Alarcón-Romero Ldel C, Espinoza-Rojo M, Parra-Rojas I. High expression of TNF alpha is associated with -308 and -238 TNF alpha polymorphisms in knee osteoarthritis. Clin Exp Med. 2014;14(1):61-7. https://doi.org/10.1007/s10238-012-0216-3
• Muñoz-Barrios S, Guzmán-Guzmán IP, Muñoz-Valle JF, Salgado-Bernabé AB, Salgado-Goytia L, Parra-Rojas I. Association of the HindIII and S447X polymorphisms in LPL gene with hypertension and type 2 diabetes in Mexican families. Dis Markers. 2012;33(6):313-20. https://doi.org/10.3233/DMA-2012-00940
• Martínez-Calleja A, Quiróz-Vargas I, Parra-Rojas I, Muñoz-Valle JF, Leyva-Vázquez MA, Fernández-Tilapa G, Vences-Velázquez A, Cruz M, Salazar-Martínez E, Flores-Alfaro E. Haplotypes in the CRP Gene Associated with Increased BMI and Levels of CRP in Subjects with Type 2 Diabetes or Obesity from Southwestern Mexico. Exp Diabetes Res. 2012;2012:982683. https://doi.org/10.1155/2012/982683
• Martínez-Cortés G, Salazar-Flores J, Fernández-Rodríguez LG, Rubi-Castellanos R, Rodríguez-Loya C, Velarde-Félix JS, Muñoz-Valle JF, Parra-Rojas I, Rangel-Villalobos H. Admixture and population structure in Mexican-Mestizos based on paternal lineages. J Hum Genet. 2012;57(9):568-74. https://doi.org/10.1038/jhg.2012.67
• Guzmán-Guzmán IP, Salgado-Goytia L, Muñoz-Valle JF, Salgado-Bernabé AB, Quiroz-Vargas I, Parra-Rojas I. Prehypertension in a Mexican population: influence of age, gender, and body fat. Clin Exp Hypertens. 2013;35(1):67-73. https://doi.org/10.3109/10641963.2012.690470
• Flores-Alfaro E, Fernández-Tilapa G, Salazar-Martínez E, Cruz M, Illades-Aguiar B, Parra-Rojas I. Common variants in the CRP gene are associated with serum C-reactive protein levels and body mass index in healthy individuals in Mexico. Genet mol Res. 2012; 11(3): 2258-67. Genet Mol Res. https://doi.org/10.4238/2012.May.14.5
• De la Cruz-Mosso U, Muñoz-Valle JF, Salgado-Goytia L, García-Carreón A, Illades-Aguiar B, Castañeda-Saucedo E, Parra-Rojas I. Relationship of metabolic syndrome and its components with -844 G/A and HindIII C/G PAI-1 gene polymorphisms in Mexican children. BMC Pediatr. 2012;12:41. https://doi.org/10.1186/1471-2431-12-41
• Muñoz-Valle JF, Ruiz-Quezada SL, Oregón-Romero E, Navarro-Hernández RE, Castañeda-Saucedo E, De la Cruz-Mosso U, Illades-Aguiar B, Leyva-Vázquez MA, Castro-Alarcón N, Parra-Rojas I. PAI-1 mRNA expression and plasma level in rheumatoid arthritis: relationship with 4G/5G PAI-1 polymorphism. Rheumatol Int. 2012;32(12):3951-6. https://doi.org/10.1007/s00296-011-2279-y
• Ramos-Arellano LE, Benito-Damián F, Salgado-Goytia L, Muñoz-Valle JF, Guzmán-Guzmán IP, Vences-Velázquez A, Castro-Alarcón N, Parra-Rojas I. Body fat distribution and its association with hypertension in a sample of Mexican children. J Investig Med. 2011;59(7):1116-20. https://doi.org/10.3233/DMA-2011-0760
• Castro-Alarcón N, Ribas-Aparicio RM, Silva-Sánchez J, Calderón-Navarro A, Sánchez-Pérez A, Parra-Rojas I, Aparicio-Ozores G. Molecular typing and characterization of macrolide, lincosamide and streptogramin resistance in Staphylococcus epidermidis strains isolated in a Mexican hospital. J Med Microbiol. 2011;60(Pt 6):730-6. https://doi.org/10.1099/jmm.0.027847-0
• Muñoz-Valle JF, Torres-Carrillo NM, Guzmán-Guzmán IP, Torres-Carrillo N, Ruiz-Quezada SL, Palafox-Sánchez CA, Rangel-Villalobos H, Ramírez-Dueñas MG, Parra-Rojas I, Fafutis-Morris M, Bastidas-Ramírez BE, Pereira-Suárez AL. The functional class evaluated in rheumatoid arthritis is associated with soluble TGF-β1 serum levels but not with G915C (Arg25Pro) TGF-β1 polymorphism. Rheumatol Int. 2012;32(2):367-72. https://doi.org/10.1007/s00296-010-1624-x
• Guzmán-Guzmán IP, Muñoz-Valle JF, Flores-Alfaro E, Salgado-Goytia L, Salgado-Bernabé AB, Parra-Rojas I. Interleukin-6 gene promoter polymorphisms and cardiovascular risk factors. A family study. Dis Markers. 2010;28(1):29-36. https://doi.org/10.3233/DMA-2010-0680
• Muñoz-Valle JF, Valle Y, Padilla-Gutiérrez JR, Parra-Rojas I, Rangel-Villalobos H, Vázquez del Mercado M, Ledezma-Lozano IY, Villafan-Bernal JR, Armendáriz-Borunda J, Pereira-Suárez AL. The +49A>G CTLA-4 polymorphism is associated with rheumatoid arthritis in Mexican population. Clin Chim Acta. 2010;411(9-10):725-8. https://doi.org/10.1016/j.cca.2010.02.001
• Flores-Alfaro E, Parra-Rojas I, Salgado-Bernabé AB, Chávez-Maldonado JP, Salazar-Martínez Cardiovascular risk evaluated by C-reactive protein levels in diabetic and obese Mexican subjects. Circ J. 2008; 72(7):1170-4. https://doi.org/10.1253/circj.72.1170
• Torres-Carrillo N, Magdalena Torres-Carrillo N, Vázquez-Del Mercado M, Rangel-Villalobos H, Parra-Rojas I, Sánchez-Enríquez S, Muñoz-Valle JF. Distribution of –844 G/A and Hind III C/G PAI-1 polymorphisms and plasma PAI-1 levels in Mexican subjects: comparison of frequencies between populations. Clin Appl Thromb Hemost. 2008;14(2):220-6. https://doi.org/10.1177/1076029607304747
• Torres-Carrillo NM, Torres-Carrillo N, Vázquez-Del Mercado M, Delgado-Rizo V, Oregón-Romero E, Parra-Rojas I, Muñoz-Valle JF. The -844 G/A PAI-1 polymorphism is associated with mRNA expression in rheumatoid arthritis. Rheumatol Int. 2008;28(4):355-60. https://link.springer.com/article/10.1007%2Fs00296-007-0453-z
• Parra-Rojas I, Ruíz-Madrigal B, Martínez-López E, Panduro A. Influence of the -308 TNF-alpha and -174 IL-6 polymorphisms on lipid profile in Mexican subjects. Hereditas. 2006;143(2006):167-72. https://doi.org/10.1111/j.2006.0018-0661.01936.x
• Flores-Alfaro E, Parra-Rojas I, Jiménez-Acevedo A, Fernández-Tilapa G. [Presumptive tests in screening for detecting urinary tract infections in patients with diabetes type-2]. Salud Publica Mex. 2005; 47:376-380. https://doi.org/10.1590/S0036-36342005000500008
• Ruiz-Quezada S, Vázquez-Del Mercado M, Parra-Rojas I, Rangel-Villalobos H, Best-Aguilera C, Sánchez-Orozco LV, et al. Genotype and allele frequency of PAI-1 promoter polymorphism in healthy subjects from the west of Mexico. Association with biochemical and hematological parameters. Ann Genet. 2004;47(2):155-62. https://doi.org/10.1016/j.anngen.2003.12.001

Proyectos de Investigación

Responsable

• Expresión de citosinas en el tejido adiposo de personas obesas seropositivas o negativas al adenovirus-36. Estancia posdoctoral 2016.
• Caracterización del tejido adiposo, expresión de adipocinas y papel de HIF-1 en personas obesas seropositivas o negativas al adenovirus 36. Financiado por CONACyT, CB-2014-01.
• Evaluación de biomarcadores de uso clínico en enfermedades crónicas, infecciosas y cáncer. Cátedras CONACYT para Jóvenes Investigadores 2014-01.
• Equipamiento de los laboratorios del Cuerpo Académico Consolidado de Enfermedades Crónico Degenerativas e Infecciosas de la Universidad Autónoma de Guerrero. Financiado por CONACyT para el Apoyo al Fortalecimiento y Desarrollo de la Infraestructura Científica y Tecnológica, 2014.
• Identificación de personas obesas metabólicamente sanas y su relación con la sensibilidad a la insulina como factor protector. Financiado por la Universidad Autónoma de Guerrero, 2013.
• Fortalecimiento del Doctorado en Ciencias Biomédicas de la Universidad Autónoma de Guerrero para su ingreso al PNPC. Financiado por el Fondo Mixto CONACyT-Gobierno del Estado de Guerrero, 2010.

Participante

• Fortalecimiento de la Maestría en Ciencias Biomédicas. Clave: 249719. Financiado por CONACYT. FOMIX-CONACYT-GUERRERO. 2015-2018.
• Fortalecimiento del Doctorado en Ciencias Biomédicas. Financiado por FOMIX-CONACYT-GUERRERO. 2015-2018.